Verified
Last Review: 2026-07-17
| Forrest Ia/Ib | 55–90% risk of recurrence |
| Forrest IIa | 43–55% risk of recurrence |
| Forrest IIb | 22–33% risk of recurrence |
| Forrest IIc/III | < 5% risk of recurrence |
Forrest JA et al. • Lancet. 1974;2(7877):394-7. The foundational paper establishing the nomenclature.
View Source• . ;
Laine L et al. • American Journal of Gastroenterology. 2012;107(3):345-60. ACG guideline formalizing the role of Forrest-driven therapy.
View SourceLast Comprehensive Review: 2026-07-17
Scanning Medical Journals
No new significant updates or guidelines matching this topic were found today. We will check again soon.
